Cullinan Therapeutics (CGEM) Shares Issued: 2020-2023
- Cullinan Therapeutics' Shares Issued rose 8933.10% to $38.4 million in Q2 2023 from the same period last year, while for Jun 2023 it was $39.5 million, marking a year-over-year decrease of 85.31%. This contributed to the annual value of $262.7 million for FY2024, which is 584.20% up from last year.
- As of Q2 2023, Cullinan Therapeutics' Shares Issued stood at $38.4 million, which was up 106,833.33% from -$36,000 recorded in Q1 2023.
- Cullinan Therapeutics' 5-year Shares Issued high stood at $267.3 million for Q1 2021, and its period low was -$435,000 during Q2 2022.
- Its 3-year average for Shares Issued is $61.4 million, with a median of $1.6 million in 2022.
- Examining YoY changes over the last 5 years, Cullinan Therapeutics' Shares Issued showed a top increase of 8,933.10% in 2023 and a maximum decrease of 102.27% in 2023.
- Cullinan Therapeutics' Shares Issued (Quarterly) stood at $800,000 in 2020, then skyrocketed by 1,775.56% to $267.3 million in 2021, then plummeted by 99.41% to -$435,000 in 2022, then spiked by 8,933.10% to $38.4 million in 2023.
- Its last three reported values are $38.4 million in Q2 2023, -$36,000 for Q1 2023, and -$435,000 during Q2 2022.
